Trust and confidence are critical to the success of the economic models, and validation of how well the model reflects “reality” is a key component of the model development process.16 The question is then whether payers could put trust and confidence in a model that uses a surrogate endpoint such as JAK2 to predict DP and survival of PV? This evidence concerns the gene JAK2 and acquired polycythemia vera.